Equity Research, Broker Reports, and media content on ImmuPharma plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ImmuPharma plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

ImmuPharma plc

Company Profile

  • Personnel
  • Dimitri Dimitriou, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ImmuPharma plc. We currently have 91 research reports from 7 professional analysts.

  • Open: 7.00p
  • Range Today: 6.93/7.38p
  • 52 Week: 6.65/14.8p
  • Daily Volume: 262.1k
  • Daily Liquidity: (0.10%)
  • # Shares: 250.2m
  • Market Cap: £17.6m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
11Oct21 16:35 RNS Immupharma PLC - Price Monitoring Extension
01Oct21 07:00 RNS Immupharma PLC - Euronext Delisting
30Sep21 07:15 RNS Immupharma PLC - PROF. SYLVIANE MULLER AWARDED ‘LEGION D’HONNEUR’
29Sep21 07:30 RNS Immupharma PLC - Interim Results for the 6months ended 30 June 2021
29Sep21 07:00 RNS Immupharma PLC - Corporate Update
22Sep21 16:41 RNS Immupharma PLC - Second Price Monitoring Extn
22Sep21 16:36 RNS Immupharma PLC - Price Monitoring Extension
  • Frequency of research reports

     

  • Research reports on

    ImmuPharma plc

  • Providers covering

    ImmuPharma plc